Global Vonoprazan Fumarate API Market Research Report 2025

Publication ID:

PB501254518

Publication Date:

February 5, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Vonoprazan Fumarate API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Vonoprazan Fumarate(CAS锛�1260141-27-2) is the fumarate salt form of vonoprazan, a pyrrole derivative and reversible potassium-competitive acid blocker (P-CAB), with potential antacid activity.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vonoprazan Fumarate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vonoprazan Fumarate API.
The Vonoprazan Fumarate API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vonoprazan Fumarate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vonoprazan Fumarate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ami Lifesciences Private Limited
Dr. Reddy's Laboratories
Hetero Drugs
Metrochem API Private Limited
Nippon Zhenlei Chemical
Virupaksha Organics
Zhejiang Hengkang Pharmaceutical
Maithri Drugs
Xian Wanlong Pharmaceutical
Morepen Laboratories
by Type
Above 98 %
Above 99 %
by Application
Tablets
Others
Production by Region
India
China
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vonoprazan Fumarate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Vonoprazan Fumarate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Vonoprazan Fumarate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Vonoprazan Fumarate API Market Overview
1.1 Product Definition
1.2 Vonoprazan Fumarate API by Type
1.2.1 Global Vonoprazan Fumarate API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Vonoprazan Fumarate API by Application
1.3.1 Global Vonoprazan Fumarate API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Vonoprazan Fumarate API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Vonoprazan Fumarate API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Vonoprazan Fumarate API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Vonoprazan Fumarate API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Vonoprazan Fumarate API Production Market Share by Manufacturers (2020-2025)
2.2 Global Vonoprazan Fumarate API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Vonoprazan Fumarate API, Industry Ranking, 2023 VS 2024
2.4 Global Vonoprazan Fumarate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Vonoprazan Fumarate API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Vonoprazan Fumarate API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Vonoprazan Fumarate API, Product Offered and Application
2.8 Global Key Manufacturers of Vonoprazan Fumarate API, Date of Enter into This Industry
2.9 Vonoprazan Fumarate API Market Competitive Situation and Trends
2.9.1 Vonoprazan Fumarate API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Vonoprazan Fumarate API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Vonoprazan Fumarate API Production by Region
3.1 Global Vonoprazan Fumarate API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Vonoprazan Fumarate API Production Value by Region (2020-2031)
3.2.1 Global Vonoprazan Fumarate API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Vonoprazan Fumarate API by Region (2026-2031)
3.3 Global Vonoprazan Fumarate API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Vonoprazan Fumarate API Production Volume by Region (2020-2031)
3.4.1 Global Vonoprazan Fumarate API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Vonoprazan Fumarate API by Region (2026-2031)
3.5 Global Vonoprazan Fumarate API Market Price Analysis by Region (2020-2025)
3.6 Global Vonoprazan Fumarate API Production and Value, Year-over-Year Growth
3.6.1 India Vonoprazan Fumarate API Production Value Estimates and Forecasts (2020-2031)
3.6.2 China Vonoprazan Fumarate API Production Value Estimates and Forecasts (2020-2031)
4 Vonoprazan Fumarate API Consumption by Region
4.1 Global Vonoprazan Fumarate API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Vonoprazan Fumarate API Consumption by Region (2020-2031)
4.2.1 Global Vonoprazan Fumarate API Consumption by Region (2020-2025)
4.2.2 Global Vonoprazan Fumarate API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Vonoprazan Fumarate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Vonoprazan Fumarate API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Vonoprazan Fumarate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Vonoprazan Fumarate API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Vonoprazan Fumarate API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Vonoprazan Fumarate API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Vonoprazan Fumarate API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Vonoprazan Fumarate API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Vonoprazan Fumarate API Production by Type (2020-2031)
5.1.1 Global Vonoprazan Fumarate API Production by Type (2020-2025)
5.1.2 Global Vonoprazan Fumarate API Production by Type (2026-2031)
5.1.3 Global Vonoprazan Fumarate API Production Market Share by Type (2020-2031)
5.2 Global Vonoprazan Fumarate API Production Value by Type (2020-2031)
5.2.1 Global Vonoprazan Fumarate API Production Value by Type (2020-2025)
5.2.2 Global Vonoprazan Fumarate API Production Value by Type (2026-2031)
5.2.3 Global Vonoprazan Fumarate API Production Value Market Share by Type (2020-2031)
5.3 Global Vonoprazan Fumarate API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Vonoprazan Fumarate API Production by Application (2020-2031)
6.1.1 Global Vonoprazan Fumarate API Production by Application (2020-2025)
6.1.2 Global Vonoprazan Fumarate API Production by Application (2026-2031)
6.1.3 Global Vonoprazan Fumarate API Production Market Share by Application (2020-2031)
6.2 Global Vonoprazan Fumarate API Production Value by Application (2020-2031)
6.2.1 Global Vonoprazan Fumarate API Production Value by Application (2020-2025)
6.2.2 Global Vonoprazan Fumarate API Production Value by Application (2026-2031)
6.2.3 Global Vonoprazan Fumarate API Production Value Market Share by Application (2020-2031)
6.3 Global Vonoprazan Fumarate API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Ami Lifesciences Private Limited
7.1.1 Ami Lifesciences Private Limited Vonoprazan Fumarate API Company Information
7.1.2 Ami Lifesciences Private Limited Vonoprazan Fumarate API Product Portfolio
7.1.3 Ami Lifesciences Private Limited Vonoprazan Fumarate API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Ami Lifesciences Private Limited Main Business and Markets Served
7.1.5 Ami Lifesciences Private Limited Recent Developments/Updates
7.2 Dr. Reddy's Laboratories
7.2.1 Dr. Reddy's Laboratories Vonoprazan Fumarate API Company Information
7.2.2 Dr. Reddy's Laboratories Vonoprazan Fumarate API Product Portfolio
7.2.3 Dr. Reddy's Laboratories Vonoprazan Fumarate API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.2.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.3 Hetero Drugs
7.3.1 Hetero Drugs Vonoprazan Fumarate API Company Information
7.3.2 Hetero Drugs Vonoprazan Fumarate API Product Portfolio
7.3.3 Hetero Drugs Vonoprazan Fumarate API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Hetero Drugs Main Business and Markets Served
7.3.5 Hetero Drugs Recent Developments/Updates
7.4 Metrochem API Private Limited
7.4.1 Metrochem API Private Limited Vonoprazan Fumarate API Company Information
7.4.2 Metrochem API Private Limited Vonoprazan Fumarate API Product Portfolio
7.4.3 Metrochem API Private Limited Vonoprazan Fumarate API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Metrochem API Private Limited Main Business and Markets Served
7.4.5 Metrochem API Private Limited Recent Developments/Updates
7.5 Nippon Zhenlei Chemical
7.5.1 Nippon Zhenlei Chemical Vonoprazan Fumarate API Company Information
7.5.2 Nippon Zhenlei Chemical Vonoprazan Fumarate API Product Portfolio
7.5.3 Nippon Zhenlei Chemical Vonoprazan Fumarate API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Nippon Zhenlei Chemical Main Business and Markets Served
7.5.5 Nippon Zhenlei Chemical Recent Developments/Updates
7.6 Virupaksha Organics
7.6.1 Virupaksha Organics Vonoprazan Fumarate API Company Information
7.6.2 Virupaksha Organics Vonoprazan Fumarate API Product Portfolio
7.6.3 Virupaksha Organics Vonoprazan Fumarate API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Virupaksha Organics Main Business and Markets Served
7.6.5 Virupaksha Organics Recent Developments/Updates
7.7 Zhejiang Hengkang Pharmaceutical
7.7.1 Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Company Information
7.7.2 Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Product Portfolio
7.7.3 Zhejiang Hengkang Pharmaceutical Vonoprazan Fumarate API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Zhejiang Hengkang Pharmaceutical Main Business and Markets Served
7.7.5 Zhejiang Hengkang Pharmaceutical Recent Developments/Updates
7.8 Maithri Drugs
7.8.1 Maithri Drugs Vonoprazan Fumarate API Company Information
7.8.2 Maithri Drugs Vonoprazan Fumarate API Product Portfolio
7.8.3 Maithri Drugs Vonoprazan Fumarate API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Maithri Drugs Main Business and Markets Served
7.8.5 Maithri Drugs Recent Developments/Updates
7.9 Xian Wanlong Pharmaceutical
7.9.1 Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Company Information
7.9.2 Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Product Portfolio
7.9.3 Xian Wanlong Pharmaceutical Vonoprazan Fumarate API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Xian Wanlong Pharmaceutical Main Business and Markets Served
7.9.5 Xian Wanlong Pharmaceutical Recent Developments/Updates
7.10 Morepen Laboratories
7.10.1 Morepen Laboratories Vonoprazan Fumarate API Company Information
7.10.2 Morepen Laboratories Vonoprazan Fumarate API Product Portfolio
7.10.3 Morepen Laboratories Vonoprazan Fumarate API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Morepen Laboratories Main Business and Markets Served
7.10.5 Morepen Laboratories Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Vonoprazan Fumarate API Industry Chain Analysis
8.2 Vonoprazan Fumarate API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Vonoprazan Fumarate API Production Mode & Process Analysis
8.4 Vonoprazan Fumarate API Sales and Marketing
8.4.1 Vonoprazan Fumarate API Sales Channels
8.4.2 Vonoprazan Fumarate API Distributors
8.5 Vonoprazan Fumarate API Customer Analysis
9 Vonoprazan Fumarate API Market Dynamics
9.1 Vonoprazan Fumarate API Industry Trends
9.2 Vonoprazan Fumarate API Market Drivers
9.3 Vonoprazan Fumarate API Market Challenges
9.4 Vonoprazan Fumarate API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Ami Lifesciences Private Limited
Dr. Reddy's Laboratories
Hetero Drugs
Metrochem API Private Limited
Nippon Zhenlei Chemical
Virupaksha Organics
Zhejiang Hengkang Pharmaceutical
Maithri Drugs
Xian Wanlong Pharmaceutical
Morepen Laboratories

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂